163 related articles for article (PubMed ID: 10340403)
21. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
Bettinardi A; Brugnoni D; Quiròs-Roldan E; Malagoli A; La Grutta S; Correra A; Notarangelo LD
Blood; 1997 Feb; 89(3):902-9. PubMed ID: 9028321
[TBL] [Abstract][Full Text] [Related]
22. Residual CD95-pathway function in children with autoimmune lymphoproliferative syndrome is independent from clinical state and genotype of CD95 mutation.
Fuchs H; Posovszky C; Lahr G; van der Werff ten Bosch J; Boehler T; Debatin KM
Pediatr Res; 2009 Feb; 65(2):163-8. PubMed ID: 18948840
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
Jackson CE; Fischer RE; Hsu AP; Anderson SM; Choi Y; Wang J; Dale JK; Fleisher TA; Middelton LA; Sneller MC; Lenardo MJ; Straus SE; Puck JM
Am J Hum Genet; 1999 Apr; 64(4):1002-14. PubMed ID: 10090885
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
Dianzani U; Bragardo M; DiFranco D; Alliaudi C; Scagni P; Buonfiglio D; Redoglia V; Bonissoni S; Correra A; Dianzani I; Ramenghi U
Blood; 1997 Apr; 89(8):2871-9. PubMed ID: 9108407
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis.
Kanegane H; Vilela MM; Wang Y; Futatani T; Matsukura H; Miyawaki T
Pediatr Nephrol; 2003 May; 18(5):454-6. PubMed ID: 12736807
[TBL] [Abstract][Full Text] [Related]
26. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
Rieux-Laucat F; Le Deist F; Hivroz C; Roberts IA; Debatin KM; Fischer A; de Villartay JP
Science; 1995 Jun; 268(5215):1347-9. PubMed ID: 7539157
[TBL] [Abstract][Full Text] [Related]
27. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations.
Vaishnaw AK; Toubi E; Ohsako S; Drappa J; Buys S; Estrada J; Sitarz A; Zemel L; Chu JL; Elkon KB
Arthritis Rheum; 1999 Sep; 42(9):1833-42. PubMed ID: 10513797
[TBL] [Abstract][Full Text] [Related]
28. Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma.
van den Berg A; Maggio E; Diepstra A; de Jong D; van Krieken J; Poppema S
Blood; 2002 Feb; 99(4):1492-4. PubMed ID: 11830507
[TBL] [Abstract][Full Text] [Related]
29. [Autoimmune lymphoproliferative syndrome: molecular diagnosis in two families].
Cambronero R; Cámara C; López-Granados E; Ferreira A; Fontán G; García Rodríguez MC
Med Clin (Barc); 2003 May; 120(16):622-5. PubMed ID: 12732128
[TBL] [Abstract][Full Text] [Related]
30. Investigation of suspected deficient Fas-mediated apoptosis in a father and son.
Hanlon MG; Gacis ML; Kakakios AM; Kilham H
Cytometry; 2001 Mar; 43(3):195-8. PubMed ID: 11170106
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
Jackson CE; Puck JM
Curr Opin Pediatr; 1999 Dec; 11(6):521-7. PubMed ID: 10590910
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune lymphoproliferative syndrome: types I, II and beyond.
Chun HJ; Lenardo MJ
Adv Exp Med Biol; 2001; 490():49-57. PubMed ID: 11505974
[No Abstract] [Full Text] [Related]
33. Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
van der Burg M; de Groot R; Comans-Bitter WM; den Hollander JC; Hooijkaas H; Neijens HJ; Berger RM; Oranje AP; Langerak AW; van Dongen JJ
Pediatr Res; 2000 Mar; 47(3):336-43. PubMed ID: 10709732
[TBL] [Abstract][Full Text] [Related]
34. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
Straus SE; Sneller M; Lenardo MJ; Puck JM; Strober W
Ann Intern Med; 1999 Apr; 130(7):591-601. PubMed ID: 10189330
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic studies in lymphocyte apoptosis and human autoimmunity.
Martin DA; Combadiere B; Hornung F; Jiang D; McFarland H; Siegel R; Trageser C; Wang J; Zheng L; Lenardo MJ
Novartis Found Symp; 1998; 215():73-82; discussion 82-91. PubMed ID: 9760572
[TBL] [Abstract][Full Text] [Related]
36. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Del-Rey M; Ruiz-Contreras J; Bosque A; Calleja S; Gomez-Rial J; Roldan E; Morales P; Serrano A; Anel A; Paz-Artal E; Allende LM
Blood; 2006 Aug; 108(4):1306-12. PubMed ID: 16627752
[TBL] [Abstract][Full Text] [Related]
37. The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.
Deutsch M; Tsopanou E; Dourakis SP
Clin Rheumatol; 2004 Feb; 23(1):43-4. PubMed ID: 14749982
[TBL] [Abstract][Full Text] [Related]
38. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
Drappa J; Vaishnaw AK; Sullivan KE; Chu JL; Elkon KB
N Engl J Med; 1996 Nov; 335(22):1643-9. PubMed ID: 8929361
[TBL] [Abstract][Full Text] [Related]
39. Light microscopic, immunophenotypic, and molecular genetic study of autoimmune lymphoproliferative syndrome caused by fas mutation.
Kraus MD; Shenoy S; Chatila T; Hess JL
Pediatr Dev Pathol; 2000; 3(1):101-9. PubMed ID: 10594139
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
